Abstract
Pseudomonas aeruginosa MTCC 7925, a sludge isolate, was found to synthesize a novel short-chain-lengthlong- chain-length (SCL-LCL) co-polymer with 3-hydroxybutyric acid (3HB), 3-hydroxyvaleric acid (3HV), 3- hydroxyhexadecanoic acid (3HHD) and 3-hydroxyoctadecanoic acid (3HOD) as constituents. Under batch mode study, cells harvested at the stationary phase of growth depicted maximum PHAs accumulation, i.e. 24% of dry cell weight (dcw) at 48 h of incubation. The co-polymer accumulation was raised to 49% (dcw) under 2% ethanol-supplemented condition. A further, rise up to 78% (dcw) was recorded by optimizing the critical variables by Response Surface Methodology (RSM). When palm oil and its cakes were used as carbon sources, yield of 5.9 g/l was achieved, which was almost 85-fold higher against control. The thermal and mechanical properties of the polymer are comparable with polypropylene and polyethylene, thus opening new possibilities for various industrial applications.
Keywords: Inexpensive carbon sources, N-deficiency, P-deficiency, PHAs, Pseudomonas aeruginosa MTCC 7925, RSM, SCL-LCL-PHA co-polymer
Current Biotechnology
Title:Pseudomonas aeruginosa MTCC 7925: Producer of a Novel SCL-LCLPHA Co-Polymer
Volume: 2 Issue: 1
Author(s): Akhilesh Kumar Singh, Ranjana Bhati, Shilalipi Samantaray and Nirupama Mallick
Affiliation:
Keywords: Inexpensive carbon sources, N-deficiency, P-deficiency, PHAs, Pseudomonas aeruginosa MTCC 7925, RSM, SCL-LCL-PHA co-polymer
Abstract: Pseudomonas aeruginosa MTCC 7925, a sludge isolate, was found to synthesize a novel short-chain-lengthlong- chain-length (SCL-LCL) co-polymer with 3-hydroxybutyric acid (3HB), 3-hydroxyvaleric acid (3HV), 3- hydroxyhexadecanoic acid (3HHD) and 3-hydroxyoctadecanoic acid (3HOD) as constituents. Under batch mode study, cells harvested at the stationary phase of growth depicted maximum PHAs accumulation, i.e. 24% of dry cell weight (dcw) at 48 h of incubation. The co-polymer accumulation was raised to 49% (dcw) under 2% ethanol-supplemented condition. A further, rise up to 78% (dcw) was recorded by optimizing the critical variables by Response Surface Methodology (RSM). When palm oil and its cakes were used as carbon sources, yield of 5.9 g/l was achieved, which was almost 85-fold higher against control. The thermal and mechanical properties of the polymer are comparable with polypropylene and polyethylene, thus opening new possibilities for various industrial applications.
Export Options
About this article
Cite this article as:
Kumar Singh Akhilesh, Bhati Ranjana, Samantaray Shilalipi and Mallick Nirupama, Pseudomonas aeruginosa MTCC 7925: Producer of a Novel SCL-LCLPHA Co-Polymer, Current Biotechnology 2013; 2 (1) . https://dx.doi.org/10.2174/2211550111302010013
DOI https://dx.doi.org/10.2174/2211550111302010013 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
Call for Papers in Thematic Issues
Age Reversal using transient epigenetc reprogramming with the OSK Yamanaka Factors
Aging is a complex biological process characterized by a gradual deterioration of physiological functions and an increased vulnerability to disease. Recent advancements in the field of regenerative medicine have shown promising avenues for combating aging. Among these, partial epigenetic reprogramming, specifically utilizing the Yamanaka factors, has been shown to reverse ...read more
Bioinformatic Analysis of Regulated Cell Death in Chronic and Acute Inflammatory Diseases
In the intricate realm of inflammatory diseases, delving into the complexities surrounding regulated cell death emerges as an indispensable and forefront area of exploration. Understanding the intricacies of how cells are regulated to undergo death in inflammatory conditions not only represents a pivotal frontier in biomedical research but also holds ...read more
Feeding a vegan World
The Eat-Lancet Planetary diet recommends at least 2/3 plant and microbial sources in the food protein portion. Such diet is recommended against obesity, cancer and to limit global warming, and might get more and more incentives in the next years. We thus need massive amounts of Plant-based food, and the ...read more
Leveraging AI for personalized pediatric neurodevelopmental support
Personalized medicine in pediatrics is a moving target dedicated to finding the right treatment, at the right time, for each individual child in each stage of development. Child development is a highly personal process, unique to each individual, something which is even more apparent in the development of children with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
CNS & Neurological Disorders - Drug Targets Is Nicotine Protective Against Parkinson´s Disease? An Experimental Analysis
CNS & Neurological Disorders - Drug Targets Analysis of the Clinical Characteristics and Follow-up Study of Children with Cutaneous Polyarteritis Nodosa
Current Neurovascular Research Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches
CNS & Neurological Disorders - Drug Targets Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs
Current Medicinal Chemistry The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy
CNS & Neurological Disorders - Drug Targets Design, Synthesis and Molecular Docking Studies of New Potential Piperazine Derivatives as Cognition Enhancers
Central Nervous System Agents in Medicinal Chemistry Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
CNS & Neurological Disorders - Drug Targets Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation
Current Medicinal Chemistry Cortisol Regulation in the Metabolic Syndrome. A Novel Therapeutic Approach
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Mechanism Underlying the Therapeutic Activities of Propolis: A Critical Review
Current Nutrition & Food Science White Matter Damage Along the Uncinate Fasciculus Contributes to Cognitive Decline in AD and DLB
Current Alzheimer Research Role of Diagnostic Ultrasound in Patient Selection for Stroke Intervention
Recent Patents on CNS Drug Discovery (Discontinued) Cellular Pathology in the Dorsolateral Prefrontal Cortex Distinguishes Schizophrenia from Bipolar Disorder
Current Molecular Medicine Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Medicinal Properties of Neem Leaves: A Review
Current Medicinal Chemistry - Anti-Cancer Agents Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
Current Neuropharmacology